The Perfect Enemy | Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use - The Wall Street Journal
October 3, 2025

Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use – The Wall Street Journal

Julio Marchi April 29, 2022

Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use  The Wall Street JournalView Full Coverage on Google News

Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use – The Wall Street Journal
Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use – The Wall Street Journal

Paxlovid’s key advantage over other Covid-19 treatments has been that it can be taken at home to avoid hospitalization.

Photo: Fabian Sommer/Zuma Press

More Stories

Trial: Paxlovid retreatment after COVID rebound tied to faster drop in viral RNA but no clinical benefit

Trial: Paxlovid retreatment after COVID rebound tied to faster drop in viral RNA but no clinical benefit

Julio Marchi October 3, 2025
Poll shows Americans view COVID-19 vaccines as unsafe for pregnant women

Poll shows Americans view COVID-19 vaccines as unsafe for pregnant women

Julio Marchi October 2, 2025
Inhaled heparin slashes ventilation, death in COVID patients, analysis suggests

Inhaled heparin slashes ventilation, death in COVID patients, analysis suggests

Julio Marchi October 1, 2025